Focused deterrence strategies seek to minimise the most pernicious behaviour of criminal groups (such as violence) while tolerating less harmful activities.
This briefing highlights the effects of drug policy on women as producers, suppliers and consumers of drugs in order to inform and guide policy makers on practices that should be avoided, as well as highlight those policies which effectively incorporate and address women’s needs.
This IDPC Advocacy Note offers a set of recommendations based on global evidence to guide policy makers in adopting the new AU Plan of Action on Drug Control.
This paper intends to support the discussions of the high-level review by presenting global trends on the evolution of the drug problem since the adoption of the Plan of Action and by making some reflections on the way forward.
The member states of the OAS gathered in Antigua, Guatemala, adopted the Declaration of Antigua Guatemala that encourages the consideration of new approaches to the world drug problem in the Americas.
The trends and developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.
The changing rhetoric from UNODC – of flexibility and health-based policies – is very much welcomed, but the debate needs clearer legal analysis and more extensive normative guidance than the document currently provides.
This briefing paper provides an overview of drug consumption rooms from around the world, as well as information on the background, history, objectives and impacts of drug consumption rooms.
This briefing paper describes the current state of drug policy and harm reduction services in Kenya, Ethiopia, Uganda and Tanzania, and analyses the barriers and opportunities to improve access to services in these four countries.
Welcome to the second edition of the IDPC Drug Policy Guide. The Guide brings together global evidence and examples of best practice to provide guidance on the review, design and implementation of national drug policies.
This report provides a top-level overview of the long-term drug-related trends and developments at European level, while homing in on emerging problems in specific countries.
.pdf)
